Drugmakers Under Fire For Possible U.S. Price Fixing
11/4/2016 7:04:56 AM
Two prominent U.S. lawmakers on Thursday called on federal antitrust regulators to probe whether Sanofi, Eli Lilly and Co, Merck & Co Inc, and Novo Nordisk colluded to set prices for insulin and other diabetes drugs.
The request by U.S. Senator Bernie Sanders and Representative Elijah Cummings follows a similar letter they sent last fall calling for an investigation into 14 drug companies over price increases of generic drugs.
U.S. prosecutors could file the first charges by the end of the year in their subsequent criminal investigation of generic drugmakers over suspected price collusion, Bloomberg reported on Thursday. A Justice Department spokesman declined to comment.
comments powered by